問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Taichung Veterans General Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2008-07-01 - 2010-04-30
Condition/Disease
Test Drug
Participate Sites12Sites
Terminated12Sites
2007-11-01 - 2010-07-31
Participate Sites5Sites
Terminated5Sites
2009-10-01 - 2011-12-31
Participate Sites4Sites
Terminated4Sites
2011-08-02 - 2018-06-30
2011-09-29 - 2013-12-16
Non-Small Cell Lung Cancer
MM-121(SAR256212)
Participate Sites6Sites
Terminated6Sites
2021-01-30 - 2022-03-31
COVID-19
UB-612
Recruiting1Sites
Terminated11Sites
2021-10-01 - 2023-12-31
Participate Sites3Sites
Not yet recruiting2Sites
2007-09-30 - 2008-12-31
2022-01-01 - 2024-08-08
Terminated2Sites
2020-01-03 - 2021-03-08
AR-301 as Adjunct Therapy to Antibiotics in the Treatment of Ventilator-associated Pneumonia (VAP) Caused by S. aureus
AR-301 Tosatoxumab
Participate Sites10Sites
Not yet recruiting9Sites
全部
